Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02368691
Title Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC)
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors GTx
Indications

triple-receptor negative breast cancer

Therapies

Enobosarm

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.